- $10.48m
- $8.65m
- $1.35m
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.625 | 0.71 | 0.145 | 1.01 | 1.35 |
Cost of Revenue | |||||
Gross Profit | 0.108 | 0.352 | 0.141 | 1.01 | — |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 14.7 | 15.4 | 15.2 | 13.6 | 13.3 |
Operating Profit | -14.1 | -14.7 | -15 | -12.6 | -11.9 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -14 | -14.7 | -15 | -12.6 | -11.9 |
Net Income After Taxes | -14 | -14.7 | -15 | -12.6 | -11.9 |
Net Income Before Extraordinary Items | |||||
Net Income | -14 | -14.7 | -15 | -12.6 | -11.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -14 | -14.7 | -15 | -12.6 | -11.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -3.28 | -2.51 | -1.53 | -0.746 | -0.672 |